{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:19:53Z","timestamp":1787314793631,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013844","name":"Fundaci\u00f3n Mundo Sano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013844","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Argentine Ministry of Science, Technology and Productive Innovation","award":["PICT 2010 No 2148"],"award-info":[{"award-number":["PICT 2010 No 2148"]}]},{"name":"Argentine Ministry of Science, Technology and Productive Innovation","award":["BID-PICT 20013 No 2828"],"award-info":[{"award-number":["BID-PICT 20013 No 2828"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.exppara.2015.05.014","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T22:39:55Z","timestamp":1432679995000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Effects of artesunate against Trypanosma cruzi"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0179-4880","authenticated-orcid":false,"given":"Gabriela Carina","family":"Olivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Postan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela Natacha","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2015.05.014_bib0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S0100-879X1998000100015","article-title":"Cytokines in innate and acquired immunity to Trypanosma cruzi infection","volume":"31","author":"Abrahamsohn","year":"1998","journal-title":"Braz. J. Med. Biol. Res"},{"key":"10.1016\/j.exppara.2015.05.014_bib0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/mus.10338","article-title":"CBA\/J mice infected with Trypanosma cruzi: an experimental model for inflammatory myopathies","volume":"27","author":"Andersson","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.exppara.2015.05.014_bib0020","first-page":"721","article-title":"Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosma cruzi strains of different types","volume":"63","author":"Andrade","year":"1985","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.exppara.2015.05.014_bib0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0035-9203(92)90156-7","article-title":"Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains","volume":"86","author":"Andrade","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"10.1016\/j.exppara.2015.05.014_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-2478(99)00172-8","article-title":"IL-12 and IFN-gamma production, and NK cell activity, in acute and chronic experimental Trypanosma cruzi infections","volume":"71","author":"Ant\u00fanez","year":"2000","journal-title":"Immunol. Lett"},{"key":"10.1016\/j.exppara.2015.05.014_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/ijerph2005010123","article-title":"Cytokines and adhesion molecules expression in the brain in human cerebral malaria","volume":"2","author":"Armah","year":"2005","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.exppara.2015.05.014_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0163-7258(01)00140-1","article-title":"Artemisinin and its derivatives: an important new class of antimalarial agents","volume":"90","author":"Balint","year":"2001","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.exppara.2015.05.014_bib0045","first-page":"389","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosma cruzi","volume":"4","author":"Brener","year":"1962","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.exppara.2015.05.014_bib0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0166-6851(00)00302-9","article-title":"Identification of six Trypanosma cruzi lineages by sequence-characterised amplified region markers","volume":"111","author":"Brisse","year":"2000","journal-title":"Mol. Biochem. Parasitol"},{"key":"10.1016\/j.exppara.2015.05.014_bib0055","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm1744","article-title":"Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease","volume":"14","author":"Bustamante","year":"2008","journal-title":"Nat. Med"},{"key":"10.1016\/j.exppara.2015.05.014_bib0060","first-page":"16","article-title":"Dissimilar distribution of T. cruzi clones in humans after chemotherapy with allopurinol and itraconazole","volume":"88","author":"Coronado","year":"2006","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.exppara.2015.05.014_bib0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0024-3205(99)00356-2","article-title":"Current status of artemisinin and its derivatives as antimalarial drugs","volume":"66","author":"Dhingra","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.exppara.2015.05.014_bib0070","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature01813","article-title":"Artemisinins target the SERCA of Plasmodium falciparum","volume":"424","author":"Eckstein-Ludwig","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.exppara.2015.05.014_bib0075","first-page":"185","article-title":"Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies","volume":"38","author":"El Zawawy","year":"2008","journal-title":"J. Egypt. Soc. Parasitol"},{"key":"10.1016\/j.exppara.2015.05.014_bib0080","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"10.1016\/j.exppara.2015.05.014_bib0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1590\/S0037-86822012000400014","article-title":"In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii","volume":"45","author":"Gomes","year":"2012","journal-title":"Rev. Soc. Bras. Med. Trop"},{"key":"10.1016\/j.exppara.2015.05.014_bib0090","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.ijcard.2013.03.049","article-title":"Granulocyte colony-stimulating factor partially repairs the damage provoked by Trypanosma cruzi in murine myocardium","volume":"168","author":"Gonz\u00e1lez","year":"2013","journal-title":"Int. J. Cardiol"},{"key":"10.1016\/j.exppara.2015.05.014_bib0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.exppara.2010.05.010","article-title":"Trypanosma cruzi: biological characterization of an isolate from an endemic area and its susceptibility to conventional drugs","volume":"126","author":"Grosso","year":"2010","journal-title":"Exp. Parasitol"},{"key":"10.1016\/j.exppara.2015.05.014_bib0100","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.micinf.2004.09.002","article-title":"Artemisinins: activities and actions","volume":"14","author":"Haynes","year":"2004","journal-title":"Microbes Infect"},{"key":"10.1016\/j.exppara.2015.05.014_bib0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.exppara.2015.05.014_bib0110","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","article-title":"Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action","volume":"14","author":"Hou","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.exppara.2015.05.014_bib0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1086\/656917","article-title":"Tolerance and safety of nifurtimox in patients with chronic Chagas disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin. Infect. Dis"},{"key":"10.1016\/j.exppara.2015.05.014_bib0120","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1128\/IAI.65.11.4883-4887.1997","article-title":"Cytokine profile suggesting that murine cerebral malaria is an encephalitis","volume":"65","author":"Jennings","year":"1997","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.05.014_bib0125","doi-asserted-by":"crossref","first-page":"e26689","DOI":"10.1371\/journal.pone.0026689","article-title":"Effects of artesunate on parasite recrudescence and dormancy in the rodent malaria model Plasmodium vinckei","volume":"6","author":"LaCrue","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exppara.2015.05.014_bib0130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/381682","article-title":"Frequency of interferon- gamma-producing T cells specific for Trypanosma cruzi inversely correlates with disease severity in chronic human Chagas disease","volume":"18","author":"Laucella","year":"2004","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.exppara.2015.05.014_bib0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.intimp.2007.10.024","article-title":"Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation","volume":"8","author":"Li","year":"2008","journal-title":"Int. Immunopharmacol"},{"key":"10.1016\/j.exppara.2015.05.014_bib0140","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1128\/AAC.01590-06","article-title":"Impact of dual infections on chemotherapeutic efficacy in Balb\/c mice infected with major genotypes of T. cruzi","volume":"51","author":"Martins","year":"2007","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.exppara.2015.05.014_bib0145","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/jac\/dkn092","article-title":"Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosma cruzi stocks from different genotypes","volume":"61","author":"Martins","year":"2008","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.exppara.2015.05.014_bib0150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cbpa.2006.03.004","article-title":"Mode of action of natural and synthetic drugs against Trypanosma cruzi and their interaction with the mammalian host","volume":"146","author":"Maya","year":"2007","journal-title":"Comp. Biochem. Physiol. A. Mol Integr. Physiol"},{"key":"10.1016\/j.exppara.2015.05.014_bib0155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/1475-2875-12-388","article-title":"Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria","volume":"12","author":"Miranda","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.exppara.2015.05.014_bib0160","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/AAC.01544-06","article-title":"Artemisinins inhibit Trypanosma cruzi and Trypanosoma brucei and rhodesiense in vitro growth","volume":"51","author":"Mishina","year":"2007","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.exppara.2015.05.014_bib0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.44.1.150-155.2000","article-title":"Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts","volume":"44","author":"Molina","year":"2000","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.exppara.2015.05.014_bib0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0003-9861(82)90383-6","article-title":"Different behaviors of benznidazole as free radical generator with mammalian and Trypanosma cruzi microsomal preparations","volume":"218","author":"Moreno","year":"1982","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1016\/j.exppara.2015.05.014_bib0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0036-46652011000300003","article-title":"In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB\/c mice","volume":"53","author":"Mutiso","year":"2011","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.exppara.2015.05.014_bib0180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s002280050484","article-title":"Comparative pharmacokinetic study of oral and rectal formulations of artesunic acid in heal volunteers","volume":"54","author":"Navaratnam","year":"1998","journal-title":"Eur. J. Clin. Pharmacol"},{"key":"10.1016\/j.exppara.2015.05.014_bib0185","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1371\/journal.pntd.0000440","article-title":"Advancing drug innovation for neglected diseases-criteria for lead progression","volume":"3","author":"Nwaka","year":"2009","journal-title":"PLoS Negl. Trop. Dis"},{"key":"10.1016\/j.exppara.2015.05.014_bib0190","doi-asserted-by":"crossref","first-page":"e1000870","DOI":"10.1371\/journal.ppat.1000870","article-title":"Impaired innate immunity in Tlr4(\u2212\/\u2212) mice but preserved CD8+ T cell responses against Trypanosma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice","volume":"29","author":"Oliveira","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.exppara.2015.05.014_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2210-1-12","article-title":"Pharmacokinetics of artesunate after single oral administration to rats","volume":"1","author":"Olliaro","year":"2001","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.exppara.2015.05.014_bib0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S1020-49892009000100012","article-title":"Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole","volume":"25","author":"Pinto","year":"2009","journal-title":"Rev. Panam. Salud Publica"},{"key":"10.1016\/j.exppara.2015.05.014_bib0205","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/jm701168h","article-title":"Malaria-infected mice are cured by oral administration of new artemisinin derivatives","volume":"51","author":"Posner","year":"2008","journal-title":"J. Med. Chem"},{"key":"10.1016\/j.exppara.2015.05.014_bib0210","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJMct0709050","article-title":"Artesunate for the treatment of severe falciparum malaria","volume":"58","author":"Rosenthal","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.exppara.2015.05.014_bib0215","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1590\/S0037-86821983000100004","article-title":"Course of infection and histopathological lesions in mice infected with seventeen Trypanosma cruzi strains isolated from chronic patients","volume":"16","author":"Schlemper","year":"1983","journal-title":"Rev. Soc. Bras. Med. Trop"},{"key":"10.1016\/j.exppara.2015.05.014_bib0220","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/AAC.47.1.223-230.2003","article-title":"Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosma cruzi clonal genotypes","volume":"47","author":"Toledo","year":"2003","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.exppara.2015.05.014_bib0225","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/jac\/dkh224","article-title":"Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosma cruzi clonal genotypes","volume":"53","author":"Toledo","year":"2004","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.exppara.2015.05.014_bib0230","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/IAI.35.2.546-551.1982","article-title":"Genetics of murine resistance to Trypanosma cruzi","volume":"35","author":"Trischmann","year":"1982","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.05.014_bib0235","series-title":"Guidelines for the Treatment of Malaria","first-page":"26","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.exppara.2015.05.014_bib0240","author":"World Health Organization"},{"key":"10.1016\/j.exppara.2015.05.014_bib0245","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/IAI.36.2.637-644.1982","article-title":"Genetic control of responses to Trypanosma cruzi in mice: multiple genes influencing parasitaemia and survival","volume":"36","author":"Wrightsman","year":"1982","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.05.014_bib0250","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kem014","article-title":"Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase\/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes","volume":"46","author":"Xu","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.exppara.2015.05.014_bib0255","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1371\/journal.pntd.0000488","article-title":"Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Medecins Sans Frontieres","volume":"3","author":"Yun","year":"2009","journal-title":"PLoS Negl. Trop. Dis"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415001502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415001502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T13:43:31Z","timestamp":1599054211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489415001502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":50,"alternative-id":["S0014489415001502"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2015.05.014","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of artesunate against Trypanosma cruzi","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2015.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}